High expression of ladinin-1 (LAD1) predicts adverse outcomes: a new candidate docetaxel resistance gene for prostatic cancer (PCa)

Li, JP; Wang, ZM; Tie, C

Li, JP (corresponding author), 157,Xiwu Rd,Xincheng Rd, Xian 710004, Shaanxi, Peoples R China.

BIOENGINEERED, 2021; 12 (1): 5749

Abstract

Docetaxel resistance is one of the major obstacles that undermine the treatment outcome of PCa. Exploring molecular mechanisms associated with docetax......

Full Text Link